ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 331121 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 331121; 2) Community: the network communities that were significantly associated with the response to NSC 331121; 3) Molecule: the relationships between components within communities and NSC 331121; 4) MDR: the compounds that were significantly associated with the NSC 331121.

NSC Compound Enrichment Correlation
NSC 749292 3-methoxy-1-nitrosopyrido[3,2:4,5]pyrrolo[1,2-c][1,2,3]benzotriazine 0.00457614317494024 0.62671847
NSC 635448 Hydrazinecarbothioamide, 2-[1-(2-pyridinyl)ethylidene]-N,N-dimethyl-, copper bromide complex 0.00628187335688596 0.68472355
NSC 639505 Cyclopentanone, 2-[(4-morpholinyl)methyl]-5-nonylidene, hydrochloride 0.00628187335688596 0.4585375
NSC 666038 Piperidinone, 1-methyl-3,5-bis[(2-nitrophenyl) methylene]-, hydrochloride 0.00628187335688596 0.75598989
NSC 693442 Null 0.00628187335688596 0.72395372
NSC 225112 2,4,6-Quinazolinetriamine, N(6)-[(3,4-dichlorophenyl)methyl]-N(6)-ethyl-5-methyl- 0.00628187335688605 0.14626546
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.00628187335688605 0.4569291
NSC 373355 Saframycin R 0.00628187335688605 0.5069004
NSC 529108 4-Fluoro-D,L-tryptophan 0.00628187335688605 0.21738662
NSC 628000 Null 0.00628187335688605 0.35241129
Total:131  Current:29    [First] [Prev] [Next] [Last]